Fri, 19 Oct 2018 12:25:44: Midphase MM-121 fail continues Merrimack’s losing streak

Fri, 19 Oct 2018 12:14:21: ESMO: Deciphera's new data backs profile of DCC-2618 in GIST

Fri, 19 Oct 2018 11:53:37: Intellia's gene-editing ATTR treatment cuts abnormal proteins in monkeys

Fri, 19 Oct 2018 11:42:58: Parker Institute teams up with Xyphos to tame CAR-Ts

Thu, 18 Oct 2018 17:28:23: Chutes & Ladders—Merck beefs up digital team with Nike executive

Thu, 18 Oct 2018 13:59:55: Ziopharm’s R&D head joins Spectrum as CMO

Thu, 18 Oct 2018 10:38:27: Gilead, Aelix ally to trial HIV-suppressing combination

Thu, 18 Oct 2018 09:55:05: Novartis inks $2.1B Endocyte buyout, furthering radiotherapy push

Thu, 18 Oct 2018 09:48:39: 3D human neural network could aid studies in brain diseases

Thu, 18 Oct 2018 08:49:18: Afferent executives launch next-generation neuro hopeful, gaining Johnson & Johnson backing

Wed, 17 Oct 2018 21:42:54: TP Therapeutics raises $80M as CMO Countouriotis takes the helm

Wed, 17 Oct 2018 20:02:10: Johnson & Johnson takes $630M hit on RSV drug bought with Alios

Wed, 17 Oct 2018 12:39:39: Eiger chalks up one win, one loss in rare disease pipeline

Wed, 17 Oct 2018 12:24:07: Roche sheds clutch of in-licensed drugs in pipeline cull

Wed, 17 Oct 2018 11:57:34: Pharnext muscle wasting phase 3 hits primary endpoint

Wed, 17 Oct 2018 10:07:14: Improving cancer immunotherapy by controlling RNA expression

Tue, 16 Oct 2018 17:55:07: ICER weighs plan to offer trial design advice to pharma companies, for a price

Tue, 16 Oct 2018 13:14:17: As U.K. politicians fret Brexit will ‘decimate medical research,’ AstraZeneca sticks to R&D plan

Tue, 16 Oct 2018 12:28:12: Nearing phase 3, resTORbio posts new data on infection drug 

Tue, 16 Oct 2018 12:21:33: Seeking global deals, Taiho swells its U.S.-based VC fund to $300M

Mon, 15 Oct 2018 21:22:53: Revolution Medicines to absorb Warp Drive Bio into its oncology and ‘undruggable’ discovery efforts

Mon, 15 Oct 2018 13:09:39: F-star names ex-Immunocore CEO Eliot Forster as leader

Mon, 15 Oct 2018 13:09:02: Australian team discovers how one orderly protein protects against cancer

Mon, 15 Oct 2018 12:53:50: HiFiBiO buys up H-Immune, joining forces to ‘combat cancer’

Mon, 15 Oct 2018 12:38:20: Alnylam drops early filing plan for porphyria drug givosiran